Fundz

Fundz Deep Dive

Everything you need to win Gus Bassani — in one platform.

Who to reach, what to say, and why now on Gus Bassani — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Gus Bassani — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Gus Bassani, Pharm D, Appointed As Chief Executive Officer of Pcca's U.S. Business Unit

PRIVATEMar 20, 2025•about 1 year ago

Position

Chief Executive Officer

Company

PCCA

Gus Bassani
HoustonManufacturingBiotechnologyHealth CarePharmaceutical

Description

PCCA announced the appointment of Gus Bassani, a company veteran, as the chief executive officer of its US business unit, effective on April 1. Former CEO David L Sparks will become chairman of the board, and former President Jim Smith will serve as executive advisor to the board of directors.

Company Information

Company

PCCA

Location

Houston, Texas, United States

About

PCCA supports the creation of personalized medicine and innovative products that make a difference in patients' lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for PCCA's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.